Felipe Vences-Catalán

Felipe Vences-Catalán

Mountain View, California, United States
269 followers 266 connections

Join to view profile
CINVESTAV

About

I am a highly motivated biomedical scientist with 15+ years of academic research…

Activity

Join now to see all activity

Experience

  • Amgen Graphic

    Amgen

    Estados Unidos

  • -

    Estados Unidos

  • -

    Estados Unidos

Education

  • CINVESTAV

    -

  • -

  • -

Publications

  • A mutation in the human tetraspanin CD81 gene is expressed as a truncated protein but does not enable CD19 maturation and cell surface expression

    -

    Felipe Vences-Catalán*, Chiung-Chi Kuo*, Yael Sagi*, Homer Chen*, Neta Kela-Madar*, Menno C. van Zelm†, Jacques J. M. van Dongen† and Shoshana Levy*.
    Accepted
    Journal of Clinical Immunology

  • CD38 through the life of a murine B lymphocyte

    -

    Vences-Catalan, F., and Santos-Argumedo, L. (2011) IUBMB Life 63, 840-846.

    See publication

  • Consequences of two naturally occurring missense mutations in the structure and function of Bruton agammaglobulinemia tyrosine kinase

    -

    Vargas-Hernandez, A., Lopez-Herrera, G., Maravillas-Montero, J. L., Vences-Catalan, F., Mogica-Martinez, D., Rojo-Dominguez, A., Espinosa-Rosales, F. J., and Santos-Argumedo, L. (2012) IUBMB Life 64, 346-353.

  • Identification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoprotein

    -

    Al Olaby RR, Cocquerel L, Zemla A, Saas L, Dubuisson J, Vielmetter J, Vences-Catalan F et al. . PLoS One. 2014;9(10):e111333.

  • Role of an arginine-lysine rich motif in maturation and trafficking of CD19.

    Vences-Catalán F1, Kuo CC1, Levy S2.Biochem Biophys Res Commun. 2015 Sep 25;465(3):319-23

  • Tetraspanin CD81 promotes tumor growth and metastasis by modulating the functions of T regulatory and myeloid-derived suppressor cells.

    Vences-Catalan F, Rajapaksa R, Srivastava MK, Marabelle A, Kuo CC, Levy R, Levy S. Cancer Res. 2015 Sep 1

  • The CD19/CD81 complex physically interacts with CD38 but is not required to induce proliferation in mouse B lymphocytes

    -

    Vences-Catalan, F., Rajapaksa, R., Levy, S., and Santos-Argumedo, L. (2012) , Immunology 137, 48-55.

  • TSPAN33 is a novel marker of activated and malignant B cells

    -

    Luu, V. P., Hevezi, P., Vences-Catalan, F., Maravillas-Montero, J. L., White, C. A., Casali, P., Llorente, L., Jakez-Ocampo, J., Lima, G., Vilches-Cisneros, N., Flores-Gutierrez, J. P., Santos-Argumedo, L., and Zlotnik, A. (2013) , Clin Immunol 149, 388-399.

Patents

  • Humanized and chimeric monoclonal antibodies to cd81

    US WO2017218691A1

    Humanized or chimeric anti-CD81 (cluster of differentiation 81) monoclonal antibodies are provided. The antibodies bind to human CD81, and find use in various therapeutic methods, including without limitation the reduction or prevention of tumor metastasis. Further provided are heavy chain and light chain variable region sequences as well as associated complementarity-determining region (CDR) sequences.

    See patent

Honors & Awards

  • Fundacion TELMEX

    -

    2008-2012

  • M.S. Fellowship

    -

    2006-2008
    CONACyT

  • PhD Fellowship

    -

    2008-2012
    CONACyT

Languages

  • Español

    Native or bilingual proficiency

  • Inglés

    Full professional proficiency

More activity by Felipe

View Felipe’s full profile

  • See who you know in common
  • Get introduced
  • Contact Felipe directly
Join to view full profile

Explore collaborative articles

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.

Explore More

Add new skills with these courses

See all courses